[go: up one dir, main page]

TW200733970A - Recombinantly modified plasmin - Google Patents

Recombinantly modified plasmin

Info

Publication number
TW200733970A
TW200733970A TW095138805A TW95138805A TW200733970A TW 200733970 A TW200733970 A TW 200733970A TW 095138805 A TW095138805 A TW 095138805A TW 95138805 A TW95138805 A TW 95138805A TW 200733970 A TW200733970 A TW 200733970A
Authority
TW
Taiwan
Prior art keywords
plasmin
molecule
ogen
recombinantly modified
recombinantly
Prior art date
Application number
TW095138805A
Other languages
English (en)
Inventor
Philip Scuderi Jr
Vikram Arora
Jennifer A Hunt
Valery Novokhatny
Stephen R Petteway Jr
Original Assignee
Talecris Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Talecris Biotherapeutics Inc filed Critical Talecris Biotherapeutics Inc
Publication of TW200733970A publication Critical patent/TW200733970A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/484Plasmin (3.4.21.7)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW095138805A 2005-10-20 2006-10-20 Recombinantly modified plasmin TW200733970A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72861505P 2005-10-20 2005-10-20
US73258805P 2005-11-02 2005-11-02

Publications (1)

Publication Number Publication Date
TW200733970A true TW200733970A (en) 2007-09-16

Family

ID=37890850

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138805A TW200733970A (en) 2005-10-20 2006-10-20 Recombinantly modified plasmin

Country Status (3)

Country Link
US (1) US8231869B2 (zh)
TW (1) TW200733970A (zh)
WO (1) WO2007047874A2 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5026254B2 (ja) 2004-04-22 2012-09-12 グリフオルス・セラピユーテイクス・インコーポレーテツド 組換え的に改変されたプラスミン
CA2636109A1 (en) * 2006-01-06 2007-07-19 Amgen Inc. Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents
HUP0600891A2 (en) * 2006-11-30 2008-11-28 Inno Tears Kft Method and kit for measuring the status of the fibrinolytic system
WO2009073471A1 (en) * 2007-11-29 2009-06-11 Talecris Biotherapeutics, Inc. Recombinantly modified plasmin
UA103771C2 (ru) 2008-06-04 2013-11-25 Грифолз Терапьютикс Инк. Стрептокиназа, активирующая плазмин, способ и набор для получения плазмина
HUE025670T2 (en) 2009-03-03 2016-04-28 Grifols Therapeutics Inc A method for producing plasminogen
US20120220015A1 (en) * 2009-05-26 2012-08-30 Biolex Therapeutics Compositions and methods for production of aglycosylated plasminogen
EP2451835A1 (en) 2009-07-10 2012-05-16 ThromboGenics N.V. Variants of plasminogen and plasmin
WO2011023805A1 (en) * 2009-08-28 2011-03-03 Thrombogenics N.V. Use of plasmin for the treatment of filtration failure after trabeculectomy
ES2583082T3 (es) 2011-01-05 2016-09-19 Thrombogenics N.V. Variantes de plasminógeno y plasmina
WO2013024074A1 (en) 2011-08-12 2013-02-21 Thrombogenics N.V. Plasminogen and plasmin variants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776026B2 (en) * 2002-02-06 2010-08-17 Nuvue Technologies, Inc. Method for vitreous liquefaction
GB0228409D0 (en) * 2002-12-06 2003-01-08 Thromb X Nv Pharmacological vitreolysis
JP5026254B2 (ja) * 2004-04-22 2012-09-12 グリフオルス・セラピユーテイクス・インコーポレーテツド 組換え的に改変されたプラスミン

Also Published As

Publication number Publication date
US8231869B2 (en) 2012-07-31
WO2007047874A2 (en) 2007-04-26
US20100047228A1 (en) 2010-02-25
WO2007047874A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
MX2010005947A (es) Plasmina modificada de forma recombinante.
TNSN06332A1 (en) Recombinantly modified plasmin
IL235342B (en) Using hsp70 as a regulator of enzymatic activity
TW200733970A (en) Recombinantly modified plasmin
WO2002044199A3 (en) Neurotoxins with enhanced target specificity
UA103215C2 (uk) Поліпептид з ксиланазною активністю
BR112012010252A2 (pt) variantes de glicosilação de anticorpo
WO2006116949A8 (en) A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
MX2009007085A (es) Microvesiculas derivadas de levadura recombinante con actividades hemostaticas y usos de las mismas.
MX2007005202A (es) Polisacaridos de estreptococo modificados y usos de los mismos.
AU306419S (en) Arithmetic and control unit
WO2007149935A3 (en) Methods and compositions for modulating hepsin activation of urokinase-type plasminogen activator
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
AU306418S (en) Arithmetic and control unit
JP2007505079A5 (zh)
EA200801861A1 (ru) Активаторы плазминогена, имеющие сниженную способность связывать лизин
IL173104A0 (en) Siva and ubiquintination
PL1945657T3 (pl) Muteiny Tlr3 zmienione w miejscu glikozylacji i ich zastosowanie
WO2006007375A3 (en) Use of bridge-1 and activators and inhibitors thereof in the treatment of insulin deficiency and diabetes
AU304056S (en) Small holesaw boss
CA114140S (en) Cuticle nipper
AU306443S (en) Chair body
AU307100S (en) Sponge with scourer
AU304055S (en) Elongated holesaw boss